Recall: D-383-2014
Class II - Potentially Harmful
Class IIClassification
2013-10-22Initiated
TerminatedStatus
Sandoz IncorporatedFirm
Product
Tacrolimus Capsules, USP, 0.5 mg, 100 capsules/bottle, Rx only, Manufactured in India by Sandoz Private ltd. for Sandoz Inc., Princeton, NJ NDC 0781-2102-01
Reason
Cross Contamination with Other Products: findings of carryover of trace amounts of a previously manufactured product fluvastatin
Distribution
Nationwide
Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.